As of 2025-07-13, the Intrinsic Value of Repligen Corp (RGEN) is 4.46 USD. This RGEN valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 130.19 USD, the upside of Repligen Corp is -96.60%.
The range of the Intrinsic Value is 2.91 - 9.71 USD
Based on its market price of 130.19 USD and our intrinsic valuation, Repligen Corp (RGEN) is overvalued by 96.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (14.35) - (3.59) | (6.09) | -104.7% |
| DCF (Growth 10y) | 2.91 - 9.71 | 4.46 | -96.6% |
| DCF (EBITDA 5y) | 14.90 - 20.40 | 17.38 | -86.7% |
| DCF (EBITDA 10y) | 22.21 - 33.57 | 27.21 | -79.1% |
| Fair Value | -6.06 - -6.06 | -6.06 | -104.66% |
| P/E | (10.49) - (10.16) | (10.28) | -107.9% |
| EV/EBITDA | (8.47) - 14.95 | 1.98 | -98.5% |
| EPV | 19.73 - 25.05 | 22.39 | -82.8% |
| DDM - Stable | (3.98) - (15.56) | (9.77) | -107.5% |
| DDM - Multi | 8.17 - 25.12 | 12.37 | -90.5% |
| Market Cap (mil) | 7,314.07 |
| Beta | 0.91 |
| Outstanding shares (mil) | 56.18 |
| Enterprise Value (mil) | 7,146.45 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.10% |
| Cost of Debt | 5.50% |
| WACC | 7.87% |